Oxford GlycoSciences presents preliminary clinical trial results for OGT-719 at ECCO 10 Sep. 28, 1999 No Comments
Satraplatin is well tolerated but only marginally effective in cervical cancer Sep. 28, 1999 No Comments
Phase I results of Bavarian Nordic's novel pancreatic cancer therapy reported at ECCO 10 Sep. 28, 1999 No Comments
Paclitaxel/doxorubicin is superior to standard first-line therapy in metastatic breast cancer Sep. 28, 1999 No Comments
DNA-binding agents with a pyrrolylbenzimidazole skeleton claimed by Mitsui Chemicals Sep. 28, 1999 No Comments
Eisai, EORTC initiate phase I testing of novel G1-targeting anticancer sulfonamide Sep. 28, 1999 No Comments
Significant efficacy, minimal toxicity reported for radiosensitizing agent AK-2123 Sep. 27, 1999 No Comments